Investigating new treatments for infectious diseases through early phase clinical trials
Official title: Early Phase Clinical Trial Units (EPCTU)
Funded at Icon Government and Public Health Solutions, INC. · NIH-11259401 · Data updated 2026-11-12
This study is looking for people to help test new treatments for infectious diseases, with the hope of finding better ways to prevent and treat these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icon Government and Public Health Solutions, INC. NIH-funded |
| Lab location | 1 site (Hinckley, United States) |
| Project start | January 14, 2022 |
| Project end | January 13, 2026 |
| Funding year | 2025 |
| Award (this year) | $160,073 |
| NIH project number | 75N93022D00018-P00003-759302200001-1 |
| Project ID | NIH-11259401 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals with infectious diseases who are seeking new treatment options.
✕Less likely to help
Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not benefit from this research.
What this research studies
This research focuses on the Early Phase Clinical Trial Units, which are designed to explore new agents for treating and preventing infectious diseases. The approach involves implementing interventional clinical trials that assess the effectiveness and safety of these new treatments. Patients may have the opportunity to participate in trials that could lead to innovative therapies for various infectious conditions. The research aims to streamline the clinical trial process to bring new treatments to patients more efficiently.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have gone: Other research in early phase clinical trials has shown success in developing new treatments for infectious diseases, indicating a promising approach.
Where this research is happening
-
Icon Government and Public Health Solutions, INC.
Hinckley, United States Active
Researchers
- Principal investigator: Spitz, Robert — Icon Government and Public Health Solutions, INC.
- Study coordinator: Spitz, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.